Advances on the therapeutic potential of cell receptor activation in glioblastoma
- PMID: 39907852
- DOI: 10.1007/s11033-025-10312-w
Advances on the therapeutic potential of cell receptor activation in glioblastoma
Abstract
Glioblastoma multiforme is the most common and aggressive malignant brain tumor. Current therapies have been unable to improve life expectancy in patients. This cancer is frequently accompanied by overexpression of receptors, such as EGFR, VEGFR and TLRs, involved in the regulation of inflammation, cell proliferation, differentiation, and survival. The present review summarizes current knowledge from preclinical and clinical studies investigating the role of pattern recognition and tyrosine kinase receptors in glioblastoma development and evolution, and their possible use to improve treatment outcomes and patient survival.
Keywords: Cell signaling pathways; Glioblastoma.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
References
-
- WHO Classification of Tumours Editorial Board (2021) World Health Organization. Classification of Tumours of the Central Nervous System
-
- FERNANDES C, COSTA A, OSÓRIO L, LAGO RC, LINHARES P et al (2017) CARVALHO B,. Current Standards of Care in Glioblastoma Therapy. In: Glioblastoma. Codon Publications; pp. 197–241
-
- Chen Z, Hambardzumyan D (2018) Immune Microenvironment in Glioblastoma subtypes. Front Immunol. 9
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
